Literature DB >> 1028081

Pharmacokinetic studies of S-adenosyl-L-methionine (SAMe) in several animal species.

G Stramentinoli, E Catto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1028081     DOI： 10.1016/0031-6989(76)90010-2

Source DB:  PubMed          Journal:  Pharmacol Res Commun        ISSN： 0031-6989


× No keyword cloud information.
  7 in total

Review 1.  Metabolism of exogenous S-adenosyl-L-methionine in patients with liver disease.

Authors:  G L Kaye; J C Blake; A K Burroughs
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  Kinetics of S-adenosyl-L-methionine in isolated perfused rat liver and its effects on microsomal enzyme activity.

Authors:  A Guaitani; M Gualano; P Villa; G Stramentinoli; I Bartosek
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

3.  Pharmacokinetics of S-adenosyl-L-methionine in healthy volunteers.

Authors:  P Giulidori; M Cortellaro; G Moreo; G Stramentinoli
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Localization of S-[methyl-14 C]adenosyl-L-methionine in pregnant mice and fetuses as determined by autoradiography.

Authors:  G F Placidi; P Fornaro; M Guarneri; G Stramentinoli
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

Review 5.  S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism.

Authors:  H A Friedel; K L Goa; P Benfield
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

6.  Pharmacokinetic study of a novel oral formulation of S-adenosylmethionine (MSI-195) in healthy subjects: dose escalation, food effect and comparison to a commercial nutritional supplement product.

Authors:  Beth R Cameron; Ludvina Ferreira; I David MacDonald
Journal:  BMC Pharmacol Toxicol       Date:  2020-12-14       Impact factor: 2.483

7.  Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota.

Authors:  Koji Hosomi; Mayu Saito; Jonguk Park; Haruka Murakami; Naoko Shibata; Masahiro Ando; Takahiro Nagatake; Kana Konishi; Harumi Ohno; Kumpei Tanisawa; Attayeb Mohsen; Yi-An Chen; Hitoshi Kawashima; Yayoi Natsume-Kitatani; Yoshimasa Oka; Hidenori Shimizu; Mari Furuta; Yoko Tojima; Kento Sawane; Azusa Saika; Saki Kondo; Yasunori Yonejima; Haruko Takeyama; Akira Matsutani; Kenji Mizuguchi; Motohiko Miyachi; Jun Kunisawa
Journal:  Nat Commun       Date:  2022-08-18       Impact factor: 17.694
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.